Showing results (461-470 of 605) with videos related to

Sort By:
Pageof 61
Diabetes Research and Clinical Practice|June 21, 2024
The association between glycated hemoglobin levels and long-term prognosis in patients with diabetes and triple-vessel coronary disease across different age groups: A cohort studyQinxue Li, Deshan Yuan, Guyu Zeng, et al.
Lipids in Health and Disease|November 11, 2022
Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional studyTianyu Li, Deshan Yuan, Peizhi Wang, et al.
Platelets|October 23, 2018
Association of thrombocytopenia with in-hospital outcome in patients with acute ST-segment elevated myocardial infarctionRu Liu, Jia Liu, Jingang Yang, et al.
Mediators of Inflammation|June 12, 2019
Endothelial Cell Inflammation and Barriers Are Regulated by the Rab26-Mediated Balance between β2-AR and TLR4 in Pulmonary Microvessel Endothelial CellsHuaping Chen, Ming Yuan, Chunji Huang, et al.
Scientific Reports|August 13, 2021
Effect of antibiotic treatment on Oxalobacter formigenes colonization of the gut microbiome and urinary oxalate excretionLama Nazzal, Fritz Francois, Nora Henderson, et al.
BMC Cardiovascular Disorders|June 30, 2021
Real-world long-term outcomes based on three therapeutic strategies in very old patients with three-vessel diseaseDeshan Yuan, Sida Jia, Ce Zhang, et al.
Frontiers in Pharmacology|June 17, 2021
Spironolactone Improves the All-Cause Mortality and Re-Hospitalization Rates in Acute Myocardial Infarction with Chronic Kidney Disease PatientsXiang Qu, Hui Yao, Changxi Chen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 14, 2015
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: two-year results from a prospective patient-level pooled analysis of TARGET trialsZhan Gao, Ruiyan Zhang, Bo Xu, et al.
Thorax|August 4, 2016
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lungLeopoldo N Segal, Jose C Clemente, Benjamin G Wu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 28, 2025
Tertiary amine N-oxide zwitterionic lipids facilitate muscle-selective mRNA vaccine delivery for enhancing cDC1-mediated antitumor efficacyHaihong Yang, Zhan Gao, Yizi Zhou, et al.
Pageof 61